SOX2 and neoplasm: In oral squamous cell carcinoma (OSCC), higher SOX2 expression is frequently observed in well-differentiated tumours, suggesting that SOX2 may be associated with a more differentiated epithelial phenotype and correspondingly lower rates of lymph node metastasis, as well as better clinical outcomes [7].